About Brooks Hill Partners
Brooks Hill Partners is a venture capital firm founded in 2016. It is primarily based out of Waltham, United States. As of Jan 2023, Brooks Hill Partners has invested in 9 companies. It primarily invests in Seed round in Germany based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it led the Undisclosed Seed round of Cellbricks.
Overall, Brooks Hill Partners portfolio has seen 4 acquisitions, namely Deep 6 AI, 3Derm and Calibrater Health.
Brooks Hill Partners has team of 6 people including 1 partners.
Key Metrics
Brooks Hill Partners' List of Top Investments
Brooks Hill Partners has a portfolio of 9 companies. Their most notable investmentis in CellbricksTheir portfolio spans across United States, Germany and India. They have invested in Enterprise Applications, High Tech, Life Sciences听补苍诲 3 other sectors, across stages such as Seed stage. Here is the list of top investments by Brooks Hill Partners:1. Deep 6 AI
Deep 6 AI (formerly Deep 6 Analytics) develops artificial intelligence enabled solutions for clinical trial use cases. It uses AI technologies to understand the unstructured data from medical records to find more patients for clinical trials easily. It helps hospitals or pharma companies to reduce the onboarding and trail time, reduce record analysis expenses, increase patient outcome, etc.
Key facts about Deep 6 AI
- Founded Year: 2013
- Location: Pasadena (United States)
- Stage: Acquired
- Total Funding till date: $54.7M
- Employee Count: 41 as on Dec 31, 2022
- Investors: Zuma Partners, Brooks Hill Partners and 11 Others
- Latest Funding Round: Series C, Apr 26, 2022, $26.9M
- Highlight: Acquired
2.
Application based platform offering mobile CRM. The platform offers clients business mobile numbers. Its number enables customers to connect with their business. The calls between customers and clients teams are auto recorded. Clients can review all the calls using its app. Its features include sharing a business card, catalog, location, payment link, website, etc., from the call screen itself, adding customer tags, notes about sales inquiries, reminders, etc.
Key facts about SuperFone
- Founded Year: 2020
- Location: Bengaluru (India)
- Annual Revenue: 鈧�1.1Cr as on Mar 31, 2024
- Valuation: 鈧�86.3Cr as on Sep 10, 2024
- Stage: Seed
- Total Funding till date: $4.09M
- Employee Count: 36 as on Feb 28, 2025
- Investors: Brooks Hill Partners, FinSight and
- Latest Funding Round: Seed, Dec 12, 2024, $1.9M
3.
Astrocyte Pharmaceuticals is a small drug development company focussed on developing neuroprotection therapies for brain injury, concussions, stroke, and neurodegenerative disorders. It is developing its drugs that can activate astrocyte, a cell of the CNS that has the potential to treat CNS disorders such as brain injury, stroke, Alzheimer鈥檚 Disease.
Key facts about Astrocyte Pharmaceuticals
- Founded Year: 2014
- Location: Cambridge (United States)
- Stage: Series A
- Total Funding till date: $15.9M
- Investors: Brooks Hill Partners, Nest Bio Ventures and
- Latest Funding Round: Series A, Aug 21, 2023, $6M
4. 3Derm
Digital skin image analysis and disease detection tool for providers. With 3Derm, dermatologists can review images taken at medical kiosks and other referral sites to efficiently monitor high volumes of patients鈥� lesions while reserving in-office appointment times for those patients whose images indicate a more alarming condition.
Key facts about 3Derm
- Founded Year: 2012
- Location: New Haven (United States)
- Stage: Acquired
- Total Funding till date: $2.8M
- Employee Count: 41 as on Dec 31, 2021
- Investors: Brooks Hill Partners, Healthbox and 10 Others
- Latest Funding Round: Series A, Jul 22, 2019, $500K
- Highlight: Acquired
5. Totient
Developer of a drug discovery platform for cancer and autoimmune disease using artificial intelligence. The company uses immunoinformatics-algorithms, machine learning techniques, and tertiary lymphoid structures (TLS) for the identification of novel tissue-specific antigens and antibodies expressed by the cancer-affected tissues. The company develops cancer therapeutics by reconstructing antibodies from tissues affected by autoimmunity, infections, and cancer. The company has developed antibodies against novel extracellular oncology targets that include GAGE1, GAGE2A, LIVIN (BIRC7), PCNA, ANXA1, C4BPB, HCLS1, GPR83, and IL14A.
Key facts about Totient
- Founded Year: 2017
- Location: Cambridge (United States)
- Stage: Acqui-Hired
- Total Funding till date: $10.5M
- Employee Count: 26 as on Dec 31, 2022
- Investors: Viva BioInnovator, Brooks Hill Partners and 13 Others
- Latest Funding Round: Seed, Jan 05, 2021
- Highlight: Editors' Pick
Brooks Hill Partners' Year-on-Year Investment Trends
Its most recent first time investment was in Cellbricks.
Get Brooks Hill Partners' portfolio delivered to your inbox!
Brooks Hill Partners' Investments by Stage
Brooks Hill Partners has made 1 investment in Seed stage.Brooks Hill Partners' Investments by Sector
Brooks Hill Partners has a diverse portfolio, with companies operating in the High Tech, Industrial Goods and Manufacturing and Life Sciences. Notably, it has invested in 8 Enterprise (B2B) companies, 8 Tech companies, 4 Software companies and at least 3 companies focusing on Native AI.
Note: We have considered here, only first round of investments
Sector | No. of Investments |
|---|---|
High Tech | 1 |
Industrial Goods and Manufacturing | 1 |
Life Sciences | 1 |
Brooks Hill Partners' Investments by Geography
Brooks Hill Partners has made most investments in Germany (1).
Brooks Hill Partners' recent investments
Here are the most recent investments by Brooks Hill Partners:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 26, 2023 | Germany | Seed | Undisclosed | - |
Get the detailed list of all investments by Brooks Hill Partners. Download now!Acquired companies in Brooks Hill Partners' Portfolio
Here are Brooks Hill Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 11, 2025 | - | - | - | |
Jun 14, 2021 | - | - | - | |
Aug 20, 2020 | - | - | - | |
Aug 19, 2020 | - | - | - |
Team profile of Brooks Hill Partners
Brooks Hill Partners has a team of 6 members聽located in United States. Brooks Hill Partners' team does not sit on the board of any company as of now.Here is a list of all team members in Brooks Hill Partners:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | Boston | - | ||
Associate | Boston | - | ||
Associate | Boston | - | ||
Associate | Seattle | - | ||
Associate | Middlebury | - | ||
Associate | Middletown | - |
Get the full list of Brooks Hill Partners' team & partners for free. Download now!Co-investors of Brooks Hill Partners
Over the past 2 years, one investor has co-invested in Brooks Hill Partners's portfolio companies.
- Invested before Brooks Hill Partners:听TU Berlin has invested before Brooks Hill Partners.
Get full list of Brooks Hill Partners' co-investors delivered to your inbox!
Recent News related to Brooks Hill Partners
鈥�
鈥�
